Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
1991-7-19
pubmed:abstractText
The reverse transcriptase of human immunodeficiency virus type 1 is a heterodimeric protein consisting of two polypeptides with masses of 66 and 51 kDa and has, as a second enzymatic activity, RNase H activity. The 66-kDa polypeptide can be cleaved by the virus-encoded protease to yield polypeptides of 51 and 15 kDa. The latter has been characterized as possessing RNase H activity [Hansen, J., Schultze, T., Mellert, W. & Moelling, K. (1988) EMBO J. 7, 239-243]. We have purified simultaneously the heterodimeric reverse transcriptase/RNase H containing the 66/51-kDa polypeptides and the 15-kDa RNase H from Escherichia coli containing the expression vector pJS 3.7 by a procedure including chromatography on DEAE-cellulose, phosphocellulose, and heparin-Sepharose. Two RNase H and reverse transcriptase peaks were separated on phosphocellulose, one coinciding with the heterodimeric protein and the other with the 15-kDa protein. On the basis of the following findings it appears that the 15-kDa polypeptide has both RNase H and reverse transcriptase activities: (i) it copurified with both activities; (ii) it functioned as a reverse transcriptase in an in situ assay after SDS/polyacrylamide gel electrophoresis; (iii) polyclonal antibodies raised against the 66-kDa polypeptide reacted in immunoblots exclusively with a 15-kDa polypeptide, reacted in immunoblots exclusively with a 15-kDa polypeptide, while no immunoreactive bands in the range of 51-66 kDa were seen in the 15-kDa polypeptide preparation; (iv) the p15 and the p66/51 reverse transcriptase could be quantitatively pelleted in an enzymatically active form only when antibodies specific for the p66 carboxyl terminus were used; and (v) the p15 protein had bona fide properties of a reverse transcriptase and could enzymatically synthesize a high molecular weight, alkali-resistant product. The two reverse transcriptases appear to have different behaviors on various template/primer systems tested. Conceivably different forms of human immunodeficiency virus type 1 reverse transcriptases might be used in individual steps of (+)- and (-)-strand replication.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/1711222-160563, http://linkedlifedata.com/resource/pubmed/commentcorrection/1711222-1689823, http://linkedlifedata.com/resource/pubmed/commentcorrection/1711222-1691093, http://linkedlifedata.com/resource/pubmed/commentcorrection/1711222-1693146, http://linkedlifedata.com/resource/pubmed/commentcorrection/1711222-1970792, http://linkedlifedata.com/resource/pubmed/commentcorrection/1711222-1975812, http://linkedlifedata.com/resource/pubmed/commentcorrection/1711222-1988152, http://linkedlifedata.com/resource/pubmed/commentcorrection/1711222-2202146, http://linkedlifedata.com/resource/pubmed/commentcorrection/1711222-2269294, http://linkedlifedata.com/resource/pubmed/commentcorrection/1711222-2418504, http://linkedlifedata.com/resource/pubmed/commentcorrection/1711222-2430111, http://linkedlifedata.com/resource/pubmed/commentcorrection/1711222-2452083, http://linkedlifedata.com/resource/pubmed/commentcorrection/1711222-2466238, http://linkedlifedata.com/resource/pubmed/commentcorrection/1711222-2468665, http://linkedlifedata.com/resource/pubmed/commentcorrection/1711222-2790959, http://linkedlifedata.com/resource/pubmed/commentcorrection/1711222-3277667, http://linkedlifedata.com/resource/pubmed/commentcorrection/1711222-388439, http://linkedlifedata.com/resource/pubmed/commentcorrection/1711222-5432063, http://linkedlifedata.com/resource/pubmed/commentcorrection/1711222-6343758, http://linkedlifedata.com/resource/pubmed/commentcorrection/1711222-6588375, http://linkedlifedata.com/resource/pubmed/commentcorrection/1711222-942051
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
88
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
5262-66
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1991
pubmed:articleTitle
The p15 carboxyl-terminal proteolysis product of the human immunodeficiency virus type 1 reverse transcriptase p66 has DNA polymerase activity.
pubmed:affiliation
Department of Pharmacology and Biochemistry, University of Zürich-Irchel, Switzerland.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't